These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6721985)

  • 61. Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.
    Cleveland PA; Teller S; Kachevsky V; Pinili E; Evans R; Modi MW
    Drug Metab Dispos; 1991; 19(1):245-50. PubMed ID: 1673409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiotensin-converting enzyme. Investigation of diurnal variation, the effect of a large dose of prednisolone, and prednisolone pharmacokinetics in patients with sarcoidosis.
    Thompson PJ; Kemp MW; McAllister WA; Al Habet SM; Turner-Warwick ME
    Am Rev Respir Dis; 1986 Nov; 134(5):1075-7. PubMed ID: 3022627
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Normal absorption of oral prednisolone in children with active inflammatory bowel disease, including cases with proximal to distal small bowel involvement.
    Olivesi A
    Gastroenterol Clin Biol; 1985; 9(8-9):564-71. PubMed ID: 4076715
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dose-dependent disposition of ethylene glycol in the rat after intravenous administration.
    Marshall TC
    J Toxicol Environ Health; 1982 Sep; 10(3):397-409. PubMed ID: 7175970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin.
    Bergrem H; Refvem OK
    Proc Eur Dial Transplant Assoc; 1983; 19():552-7. PubMed ID: 6878255
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Altered prednisolone pharmacokinetics in patients treated with rifampicin.
    Bergrem H; Refvem OK
    Acta Med Scand; 1983; 213(5):339-43. PubMed ID: 6880856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prednisolone concentrations in plasma, saliva and urine.
    Chakraborty J; Hayes M; English J; Baylis M; Marks V
    Eur J Clin Pharmacol; 1981 Jan; 19(1):79-81. PubMed ID: 7461028
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amitriptyline disposition in young and elderly normal men.
    Schulz P; Turner-Tamiyasu K; Smith G; Giacomini KM; Blaschke TF
    Clin Pharmacol Ther; 1983 Mar; 33(3):360-6. PubMed ID: 6825390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma levels and response to prednisolone therapy in rheumatoid arthritis.
    De Silva M; Hazleman BL; Chakraborty J; English J; Marks V
    Clin Rheumatol; 1983 Sep; 2(3):299-302. PubMed ID: 6432405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.
    McAllister WA; Mitchell DM; Collins JV
    Br J Clin Pharmacol; 1981 Mar; 11(3):303-4. PubMed ID: 7194101
    [No Abstract]   [Full Text] [Related]  

  • 78. A pharmacokinetic model for prednisone after infusion to steady-state in the rabbit.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1985; 6(3):335-9. PubMed ID: 4041559
    [No Abstract]   [Full Text] [Related]  

  • 79. [Distribution of [3H]prednisolone in rat plasma and tissues after intramuscular administration of liposome-entrapped form (author's transl)].
    Shinozawa S; Araki Y; Oda T
    Yakugaku Zasshi; 1979 Jul; 99(7):693-8. PubMed ID: 544785
    [No Abstract]   [Full Text] [Related]  

  • 80. Determination of prednisolone in plasma by high-performance liquid chromatography.
    Hartley R; Brocklebank JT
    J Chromatogr; 1982 Nov; 232(2):406-12. PubMed ID: 7153287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.